VirTrial Acquires SnapMD and Bolsters Virtual Care Management Platform
December 12, 2019
Scottsdale, AZ – VirTrial,LLC (“VirTrial”), a portfolio company of Kinderhook Industries, LLC (“Kinderhook”) announced today the acquisition of SnapMD Healthcare, LLC (“SnapMD”), an industry-leading provider of telemedicine tools and services that improve patient engagement. The acquisition bolsters VirTrial’s capabilities with access to SnapMD’s telemedicine platform and technical expertise. In addition, the relationship enables integration of additional features and capabilities into VirTrial’s Virtual Care Management (VCM) platform to further establish VirTrial as the dominant global decentralized clinical trial (DCT) solution in the market.
The acquisition supports VirTrial’s goal of making hybrid decentralized clinical trials seamless for sponsors, sites, and patients. The VirTrial platform works with any device (Apple, Android, tablet and/or computer) and can be used by any site. Continuing that focus on flexibility and ease of use, new enhancements available via SnapMD technology will improve functionality and further simplify user experience.
“Our acquisition of SnapMD enables us to better implement our vision of making clinical trials easier for everyone involved from sponsors to sites and patients. By offering a simplified, straight-forward user experience and the ability for sponsors to include multiple countries with extensive features, VirTrial continues to set the bar in decentralized clinical trial platforms,” said Mark Hanley, CEO of VirTrial.
SnapMD’s VCM solution is used by providers nationwide to engage patients via a secure, HIPAA-compliant, cloud-based software platform. The company will operate as a subsidiary of VirTrial and will continue to provide its market-leading telemedicine solution across the healthcare space.
“We are extremely thrilled to join the VirTrial team and drive the evolution of telemedicine platforms in the clinical research industry,” said David Skibinski, CEO of SnapMD. “This transaction will enable SnapMD to further its commitment to improve access to care, regardless of setting, through an industry-best telemedicine solution and unmatched breadth of services.”
About SnapMD
SnapMD offers the leading enterprise-level Virtual Care Management (VCM) telehealth platform. The full-stack software solution enables healthcare providers to engage their patients via a comprehensive, secure, HIPAA/HITECH/COPPA compliant, cloud-based telemedicine platform with powerful back-end systems to manage the digital health care continuum. SnapMD offers the software and services that healthcare providers need to improve access to convenient and effective care. SnapMD’s robust, scalable, private-label VCM platform is designed to handle multiple service-lines and can be deployed as a single telehealth platform across the enterprise.
For more information, please visit www.snap.md
For additional information about this transaction, please contact:
Christian Michalik
Managing Director
(212) 201-6782
[email protected]
Michael Zoch
Managing Director
(212) 201-6785
[email protected]